Search Results

240 results for COV

Honing Our Edge In The Market Takes a Plan and Patience

By Richard Band

Stay with the plan of finding solid dividend paying stocks for the long term and that will become your long term advantage in the market.

6 Companies Increasing Dividends

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader

McDonald’s and Microsoft top this week’s list of payout performers. See who’s making shareholders smile.

Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection

By William White, InvestorPlace Writer

Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.

Why Is Finch Therapeutics (FNCH) Stock Up 30% Today?

By William White, InvestorPlace Writer

Finch Therapeutics (FNCH) stock is rising higher on Friday following news that the FDA has released its clinical hold on CP101.

5 Investors Betting Big on Novavax (NVAX) Stock

By Eddie Pan, InvestorPlace Financial News Writer

NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug.

EFOI Stock: The Product Launches That Have Energy Focus Shares Rocketing 105% Today

By William White, InvestorPlace Writer

Energy Focus (EFOI) stock is charging higher on Wednesday after launching two new products to help protect customers from Covid-19.

BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring

By William White, InvestorPlace Writer

Biondvax Pharmaceuticals (BVXV) stock is on the rise Wednesday thanks to some positive news concerning its Covid-19 antibodies.

CYTO Stock: The Nasal Spray News Blowing Altamira Therapeutics Sky-High Today

By William White, InvestorPlace Writer

Altamira Therapeutics (CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test.

ARDS Stock Alert: The Covid-19 News Sending Aridis Skyrocketing Today

By Samuel O'Brient, InvestorPlace Reporter

Aridis Pharmaceuticals has a new cocktail, and it may be the ticket out of the omicron variant. Here’s why ARDS stock is worth watching.

Short-Squeeze Stocks Alert: CVNA, NVAX Make Most-Shorted Stocks List

By Josh Enomoto, InvestorPlace Contributor

Business news outlet CNBC recently posted its list of top short-squeeze stocks, which present potentially lucrative though risky ideas.

Novavax Is Inching Closer, But Its Vaccine Better Be Special

By Todd Shriber, InvestorPlace Contributor

Novavax is trailing the competition in the coronavirus vaccine race, but markets may be punishing NVAX stock too much.

7 Small-Cap Stocks to Buy on the Dip

By Josh Enomoto, InvestorPlace Contributor

Although small-cap stocks to buy are risky, they can also yield tremendous gains as they’re largely focused on growth narratives.

Hologic Stock Rides High on Strength of Coronavirus Testing

By Louis Navellier and the InvestorPlace Research Staff

Hologic has carved out a meaningful niche in women’s health. But it’s coronavirus testing driving HOLX stock higher these days.

3 Millionaire-Maker Growth Stocks to Buy Before the Window

By Josh Enomoto, InvestorPlace Contributor

Although millionaire-maker stocks to buy present wildly outrageous risks, the intrepid may find opportunity in these ideas.

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

By Josh Enomoto, InvestorPlace Contributor

Listen to Wall Street and Buy These 3 Stocks Now

By Josh Enomoto, InvestorPlace Contributor

3 Magnificent Stocks to Buy on the Dip: February 2024

By Josh Enomoto, InvestorPlace Contributor

3 Stocks With the Largest 52-Week Losses

By Josh Enomoto, InvestorPlace Contributor

Although the stocks with largest 52-week losses are inherently risky, when the right ones are selected, they may also provide opportunities.

Upgrades This Week – BA, GIS, MSFT, NKE, PFE, GSK, MRK

By Louis Navellier, Editor, Growth Investor

Boeing (BA), General Mills (GIS), Microsoft (MSFT), and Nike (NKE) were among the widely-held stocks upgraded by Louis Navellier in his latest fundamental stock analysis…

7 Best Stocks on the Nasdaq

By Chris Lau, InvestorPlace Contributor

Investors need to hold the best companies that money can buy on the Nasdaq, amid a growing weakness in the technology stock index.

Ocugen Stock Is a Risky Proposition Despite Its High Valuation

By Divya Premkumar, InvestorPlace Contributor

OCGN stock soared on a deal to commercialize Bharat Biotech’s Covaxin in the U.S., but the rollout comes with a lot of challenges.

3 Healthcare Acquisitions Google Should Consider

By James Brumley, InvestorPlace Feature Writer

The best way for Google to make an even bigger splash in healthcare is through smart acquisitions like these 3 companies.

Why the MOAT ETF Dumped Facebook, 8 Others

By Charles Sizemore, Chief Investment Strategist, The Freeport Society

Why would a fund that tracks wide-moat companies replace half its holdings? Here’s a look at what happened, and what it means for investors.

I Would Not Be Surprised If SRNE Stock Trades Below $5

By Faisal Humayun, InvestorPlace Contributor

SRNE stock is a purely speculative bet. The company has a deep pipeline of Covid-19 programs. But there is little progress or positive outcome.

10 – 10 of 240 results